VOYA Investment Management
HRTX icon

VOYA Investment Management’s Heron Therapeutics HRTX Stock Holding History

VOYA Investment Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,601
Closed -$20.5K – 2520
2026
Q1 		$20.5K Sell
25,601
-2,052
-7% -$2.38K ﹤0.01% 2331
2025
Q4 		$35.9K Hold
27,653
– – ﹤0.01% 2366
2025
Q3 		$34.8K Sell
27,653
-15,338
-36% -$24.3K ﹤0.01% 2412
2025
Q2 		$89K Buy
42,991
+10,767
+33% +$22K ﹤0.01% 2511
2025
Q1 		$70.9K Sell
32,224
-4,177
-11% -$8.11K ﹤0.01% 2496
2024
Q4 		$55.7K Sell
36,401
-3,832
-10% -$6.21K ﹤0.01% 2664
2024
Q3 		$80.1K Buy
40,233
+676
+2% +$1.61K ﹤0.01% 2702
2024
Q2 		$138K Buy
39,557
+6,378
+19% +$19.6K ﹤0.01% 2585
2024
Q1 		$91.9K Sell
33,179
-8,176
-20% -$20.6K ﹤0.01% 2631
2023
Q4 		$70.3K Hold
41,355
– – ﹤0.01% 2818
2023
Q3 		$42.6K Hold
41,355
– – ﹤0.01% 2871
2023
Q2 		$48K Buy
41,355
+1,929
+5% +$3.44K ﹤0.01% 2903
2023
Q1 		$59.5K Hold
39,426
– – ﹤0.01% 2778
2022
Q4 		$98.6K Hold
39,426
– – ﹤0.01% 2756
2022
Q3 		$166K Hold
39,426
– – ﹤0.01% 2662
2022
Q2 		$110K Buy
39,426
+3,152
+9% +$12.7K ﹤0.01% 2589
2022
Q1 		$207K Sell
36,274
-259
-0.7% -$1.9K ﹤0.01% 2350
2021
Q4 		$333K Sell
36,533
-211,834
-85% -$2.16M ﹤0.01% 2245
2021
Q3 		$2.65M Sell
248,367
-12,552
-5% -$153K 0.01% 1054
2021
Q2 		$4.05M Buy
260,919
+35,927
+16% +$572K 0.01% 941
2021
Q1 		$3.65M Sell
224,992
-38,526
-15% -$687K 0.01% 956
2020
Q4 		$5.58M Buy
263,518
+227,045
+623% +$3.95M 0.01% 780
2020
Q3 		$541K Buy
36,473
+1,579
+5% +$24.6K ﹤0.01% 1632
2020
Q2 		$513K Sell
34,894
-7,235
-17% -$119K ﹤0.01% 1652
2020
Q1 		$495K Buy
42,129
+1,052
+3% +$19.8K ﹤0.01% 1637
2019
Q4 		$965K Buy
41,077
+12,175
+42% +$269K ﹤0.01% 1475
2019
Q3 		$535K Hold
28,902
– – ﹤0.01% 1716
2019
Q2 		$537K Buy
28,902
+647
+2% +$12.9K ﹤0.01% 1726
2019
Q1 		$691K Hold
28,255
– – ﹤0.01% 1587
2018
Q4 		$733K Buy
28,255
+1,283
+5% +$35.3K ﹤0.01% 1484
2018
Q3 		$854K Buy
26,972
+1,979
+8% +$73.7K ﹤0.01% 1499
2018
Q2 		$971K Buy
24,993
+2,982
+14% +$94.9K ﹤0.01% 1402
2018
Q1 		$608K Buy
22,011
+1,634
+8% +$37.1K ﹤0.01% 1677
2017
Q4 		$369K Hold
20,377
– – ﹤0.01% 2023
2017
Q3 		$329K Hold
20,377
– – ﹤0.01% 2120
2017
Q2 		$282K Buy
20,377
+6,267
+44% +$90.8K ﹤0.01% 2199
2017
Q1 		$212K Buy
14,110
+899
+7% +$12.4K ﹤0.01% 2243
2016
Q4 		$173K Hold
13,211
– – ﹤0.01% 2338
2016
Q3 		$228K Hold
13,211
– – ﹤0.01% 2210
2016
Q2 		$238K Hold
13,211
– – ﹤0.01% 2158
2016
Q1 		$251K Hold
13,211
– – ﹤0.01% 2101
2015
Q4 		$353K Hold
13,211
– – ﹤0.01% 1953
2015
Q3 		$322K Hold
13,211
– – ﹤0.01% 2005
2015
Q2 		$412K Sell
13,211
-4,038
-23% -$76K ﹤0.01% 2055
2015
Q1 		$251K Hold
17,249
– – ﹤0.01% 2339
2014
Q4 		$174K Hold
17,249
– – ﹤0.01% 2515
2014
Q3 		$144K Hold
17,249
– – ﹤0.01% 2567
2014
Q2 		$213K Buy
+17,249
New +$206K ﹤0.01% 2539

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

VOYA Investment Management's HRTX Position: Q2 2026 in Review

VOYA Investment Management sold out of Heron Therapeutics (HRTX) in Q2 2026, closing a stake of 25,601 shares — an estimated $20.5K sold.

VOYA Investment Management first reported a position in HRTX in Q2 2014 and held it in 48 quarters. The position peaked at $5.58M in Q4 2020. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • VOYA Investment Management reported no remaining Heron Therapeutics position as of Q2 2026 after selling out during the quarter.
  • VOYA Investment Management sold 25,601 Heron Therapeutics shares in Q2 2026, an estimated $20.5K.
  • VOYA Investment Management first reported a position in Heron Therapeutics in Q2 2014 and held it in 48 quarters.
  • VOYA Investment Management's Heron Therapeutics position peaked at $5.58M in Q4 2020.
  • 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.